UniProt ID | PFD5_HUMAN | |
---|---|---|
UniProt AC | Q99471 | |
Protein Name | Prefoldin subunit 5 | |
Gene Name | PFDN5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 154 | |
Subcellular Localization |
Isoform 1: Nucleus. Isoform 2: Cytoplasm. Isoform 3: Nucleus. |
|
Protein Description | Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. Represses the transcriptional activity of MYC.. | |
Protein Sequence | MAQSINITELNLPQLEMLKNQLDQEVEFLSTSIAQLKVVQTKYVEAKDCLNVLNKSNEGKELLVPLTSSMYVPGKLHDVEHVLIDVGTGYYVEKTAEDAKDFFKRKIDFLTKQMEKIQPALQEKHAMKQAVMEMMSQKIQQLTALGAAQATAKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAQSINITE ------CCCCCCCCC | 16.30 | 22223895 | |
4 | Phosphorylation | ----MAQSINITELN ----CCCCCCCCCCC | 14.20 | 24043423 | |
4 (in isoform 3) | Phosphorylation | - | 14.20 | 24043423 | |
8 (in isoform 3) | Phosphorylation | - | 29.90 | 24043423 | |
8 | Phosphorylation | MAQSINITELNLPQL CCCCCCCCCCCHHHH | 29.90 | 24043423 | |
26 (in isoform 3) | Phosphorylation | - | 5.39 | 24043423 | |
42 | Acetylation | QLKVVQTKYVEAKDC HHHHEEEEEECHHHH | 30.15 | 19608861 | |
42 | 2-Hydroxyisobutyrylation | QLKVVQTKYVEAKDC HHHHEEEEEECHHHH | 30.15 | - | |
42 | Ubiquitination | QLKVVQTKYVEAKDC HHHHEEEEEECHHHH | 30.15 | 27667366 | |
47 | Acetylation | QTKYVEAKDCLNVLN EEEEECHHHHHHHHC | 35.15 | 23749302 | |
47 | Malonylation | QTKYVEAKDCLNVLN EEEEECHHHHHHHHC | 35.15 | 26320211 | |
47 | Ubiquitination | QTKYVEAKDCLNVLN EEEEECHHHHHHHHC | 35.15 | 29967540 | |
49 | Ubiquitination | KYVEAKDCLNVLNKS EEECHHHHHHHHCCC | 2.69 | 21963094 | |
55 | Acetylation | DCLNVLNKSNEGKEL HHHHHHCCCCCCCCC | 50.96 | - | |
55 | Ubiquitination | DCLNVLNKSNEGKEL HHHHHHCCCCCCCCC | 50.96 | 27667366 | |
56 | Phosphorylation | CLNVLNKSNEGKELL HHHHHCCCCCCCCCE | 38.75 | 29255136 | |
60 | Ubiquitination | LNKSNEGKELLVPLT HCCCCCCCCCEEECC | 38.72 | 29967540 | |
67 | Ubiquitination | KELLVPLTSSMYVPG CCCEEECCCCEECCC | 16.82 | 21890473 | |
67 | Acetylation | KELLVPLTSSMYVPG CCCEEECCCCEECCC | 16.82 | 19608861 | |
67 | Ubiquitination | KELLVPLTSSMYVPG CCCEEECCCCEECCC | 16.82 | 22817900 | |
67 | Phosphorylation | KELLVPLTSSMYVPG CCCEEECCCCEECCC | 16.82 | 29083192 | |
68 | Phosphorylation | ELLVPLTSSMYVPGK CCEEECCCCEECCCC | 22.31 | 29083192 | |
69 | Phosphorylation | LLVPLTSSMYVPGKL CEEECCCCEECCCCC | 14.64 | 29083192 | |
71 | Phosphorylation | VPLTSSMYVPGKLHD EECCCCEECCCCCCC | 12.87 | 29083192 | |
71 | Ubiquitination | VPLTSSMYVPGKLHD EECCCCEECCCCCCC | 12.87 | 22817900 | |
79 | Ubiquitination | VPGKLHDVEHVLIDV CCCCCCCCEEEEEEC | 3.69 | 29967540 | |
90 | Phosphorylation | LIDVGTGYYVEKTAE EEECCCCEEEEECHH | 12.27 | 22817900 | |
91 | Phosphorylation | IDVGTGYYVEKTAED EECCCCEEEEECHHH | 11.95 | 27642862 | |
94 | Ubiquitination | GTGYYVEKTAEDAKD CCCEEEEECHHHHHH | 42.88 | 21906983 | |
100 | Acetylation | EKTAEDAKDFFKRKI EECHHHHHHHHHHHH | 68.35 | 27452117 | |
100 | Ubiquitination | EKTAEDAKDFFKRKI EECHHHHHHHHHHHH | 68.35 | 29967540 | |
104 | Ubiquitination | EDAKDFFKRKIDFLT HHHHHHHHHHHHHHH | 53.42 | - | |
106 | 2-Hydroxyisobutyrylation | AKDFFKRKIDFLTKQ HHHHHHHHHHHHHHH | 47.41 | - | |
108 | Ubiquitination | DFFKRKIDFLTKQME HHHHHHHHHHHHHHH | 35.22 | 21963094 | |
112 | Ubiquitination | RKIDFLTKQMEKIQP HHHHHHHHHHHHHHH | 50.20 | 22817900 | |
112 | Acetylation | RKIDFLTKQMEKIQP HHHHHHHHHHHHHHH | 50.20 | 19608861 | |
116 | Ubiquitination | FLTKQMEKIQPALQE HHHHHHHHHHHHHHH | 41.10 | 22817900 | |
116 | Acetylation | FLTKQMEKIQPALQE HHHHHHHHHHHHHHH | 41.10 | 23236377 | |
124 | Ubiquitination | IQPALQEKHAMKQAV HHHHHHHHHHHHHHH | 24.57 | 29967540 | |
124 | 2-Hydroxyisobutyrylation | IQPALQEKHAMKQAV HHHHHHHHHHHHHHH | 24.57 | - | |
124 | Acetylation | IQPALQEKHAMKQAV HHHHHHHHHHHHHHH | 24.57 | 26822725 | |
128 | Acetylation | LQEKHAMKQAVMEMM HHHHHHHHHHHHHHH | 35.57 | 25953088 | |
153 | Ubiquitination | GAAQATAKA------ HHHHHHHCC------ | 50.72 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PFD5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PFD5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PFD5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42 AND LYS-112, AND MASSSPECTROMETRY. |